GL1X · GenesisL1 explorer

Research workbench

ROR(GAMMA)T ligand binding domain in complex with allosteric ligand FM217

Analyse ROR(GAMMA)T ligand binding domain in complex with allosteric ligand FM217 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7NEC
Type
protein
Length
242 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nuclear receptor ror-gamma
UniProt
P51449
Ligands
U95
Pockets
4 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 71% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANuclear receptor ror-gammaprotein24271% helix, 4% strandP51449

Ligands and binding sites

  • U95 · 4-[[3-[2-chloranyl-6-(trifluoromethyl)phenyl]-5-(1~{H}-pyrrol-2-yl)-1,2-oxazol-4-yl]methoxy]benzoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13610.810.9033empty
22460.780.9033U95
31350.430.7518empty
4630.370.7917empty

Compared structures

  • 7NEC · ROR(gamma)t ligand binding domain in complex with allosteric ligand FM217 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.